Stay updated on Capivasertib+Abiraterone in PTEN-deficient Prostate Clinical Trial
Sign up to get notified when there's something new on the Capivasertib+Abiraterone in PTEN-deficient Prostate Clinical Trial page.

Latest updates to the Capivasertib+Abiraterone in PTEN-deficient Prostate Clinical Trial page
- Check5 days agoChange DetectedAdded Contacts/Locations and Study Status sections to the record history, reflecting updated site details and current trial status. The latest version shows these updates in the study record and status history.SummaryDifference0.3%

- Check12 days agoNo Change Detected
- Check19 days agoChange Detected- Added Revision: v3.5.0; Removed Revision: v3.4.3.SummaryDifference0.1%

- Check26 days agoChange DetectedThe record history now shows an addition of Revision: v3.4.3 and a deletion of Revision: v3.4.2.SummaryDifference0.1%

- Check55 days agoChange DetectedA new page revision entry 'Revision: v3.4.2' was added to the history, and the previous funding-lapse notice and 'Revision: v3.4.1' were removed.SummaryDifference0.4%

- Check62 days agoChange DetectedA site-wide notice about government funding and a version update to v3.4.1 (replacing v3.4.0) were added. These changes do not affect trial data or navigation on the record page; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check69 days agoChange DetectedThe study history page adds a glossary toggle, color-coded additions and deletions, and a new revision label, representing UI and formatting updates rather than changes to the underlying study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

Stay in the know with updates to Capivasertib+Abiraterone in PTEN-deficient Prostate Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Capivasertib+Abiraterone in PTEN-deficient Prostate Clinical Trial page.